Should i take isoniazid for latent tb

Diallo T et al. Safety and side effects of rifampin versus isoniazid in children. N Engl J Med Aug 2 Two new trials support rifampin as a better option than isoniazid for latent tuberculosis.

Citation s : Menzies D et al. October 16, Provo, Utah. Glens Falls, New York. Tampa, Florida. However, if latent TB bacteria become active in the body and multiply, the person will go from having latent TB infection to being sick with TB disease. For this reason, people with latent TB infection should be treated to prevent them from developing TB disease.

In the United States, up to 13 million people may have latent TB infection. Without treatment, on average 1 in 10 people with latent TB infection will get sick with TB disease in the future. The risk is higher for people with HIV, diabetes, or other conditions that affect the immune system. However, targeted TB testing programs should only be conducted among high-risk groups. All testing activities should be accompanied by a plan for follow-up care for persons with latent TB infection or disease.

All the regimens are effective. Board of Directors. Contact Us. Active Physician. Medical Student. Join AAFP. My Account. Pay Dues. Press Center. Engage with AAFP. Sponsored Resources.

Report CME. View Transcript. Skip directly to site content Skip directly to page options Skip directly to A-Z link. Tuberculosis TB. Section Navigation. Facebook Twitter LinkedIn Syndicate. Minus Related Pages.